A Phase IIIb/IV Safety Trial of Flat Dose Nivolumab in Combination With Ipilimumab in Participants With Advanced Malignancies
A study to evaluate the safety of Nivolumab given in combination with Ipilimumab in patients
with advanced cancers. The initial group will enroll patients with newly diagnosed Stage 4
or non-small cell lung cancer that has come back.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society